Effect of schistosome infection on hepatic drug metabolising enzymes
| dc.contributor.author | Naik, Yogeshkumar S. | |
| dc.contributor.author | Hasler, Julia A. | |
| dc.date.accessioned | 2014-03-18T07:17:01Z | |
| dc.date.accessioned | 2023-06-23T14:00:26Z | |
| dc.date.available | 2014-03-18T07:17:01Z | |
| dc.date.available | 2023-06-23T14:00:26Z | |
| dc.date.issued | 1998-06 | |
| dc.description | Journal article from South African Journal of Science pages 301-302 | en_US |
| dc.description.abstract | Schistosomiasis is a parasitic disease that affects over 200 million persons worldwide.' The disease is caused by infection with any one of several species that are known to affect humans. Infected persons are likely to be consuming a wide spectrum of xenobiotics such as drugs and environmental toxins. The drugs consumed would not only include praziquantel and other schistosomicides, but also those used for the treatment of other parasitic diseases such as antimalarials, anthelmintics and antibiotics. Experiments involving humans and experimental animals suggest that infection with schistosomes causes a reduction in the host's ability to metabolise and remove drugs from the body. | en_US |
| dc.identifier.citation | Naik, Yogeshkumar S. And Hasler, Julia A. (1996) Effect of schistosome infection on hepatic drug metabolising enzymes. South African Journal of Science. | en_US |
| dc.identifier.uri | http://196.220.97.103:4000/handle/123456789/378 | |
| dc.language.iso | en | en_US |
| dc.publisher | South African Journal of Science | en_US |
| dc.rights.license | This article was downloaded from NUST Institutional repository, and is made available under the terms and conditions as set out in the Institutional Repository Policy. | en_US |
| dc.subject | schistosome | en_US |
| dc.subject | hepatic | en_US |
| dc.subject | drug | en_US |
| dc.subject | enzymes | en_US |
| dc.title | Effect of schistosome infection on hepatic drug metabolising enzymes | en_US |
| dc.type | Article | en_US |